Capecitabine is a FluoropyrimidineCarbamate belonging to the class of AntineoplasticAgents called Antimetabolites. Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastaticbreast and colorectalcancers. Capecitabine was patented in 1992 and approved for medical use in 1998. It is on the WorldHealthOrganization's List of Essential Medicines.
SynZeal offers all Capecitabine related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Capecitabine related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.
